These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 37837960)
21. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer. Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039 [TBL] [Abstract][Full Text] [Related]
22. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer. Hiroshima Y; Nakamura F; Miyamoto H; Mori R; Taniguchi K; Matsuyama R; Akiyama H; Tanaka K; Ichikawa Y; Kato S; Kobayashi N; Kubota K; Nagashima Y; Goshima Y; Endo I Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S369-78. PubMed ID: 22805864 [TBL] [Abstract][Full Text] [Related]
23. Illuminating the immunological landscape: mitochondrial gene defects in pancreatic cancer through a multiomics lens. Chi H; Su L; Yan Y; Gu X; Su K; Li H; Yu L; Liu J; Wang J; Wu Q; Yang G Front Immunol; 2024; 15():1375143. PubMed ID: 38510247 [TBL] [Abstract][Full Text] [Related]
24. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice. Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868 [TBL] [Abstract][Full Text] [Related]
25. Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression. Zhu J; Chen Q; Zeng L; Gao H; Wu T; He Y; Xu J; Pang J; Peng J; Deng Y; Han Y; Yi W Front Immunol; 2023; 14():1236806. PubMed ID: 37901236 [TBL] [Abstract][Full Text] [Related]
26. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma. Chen CC; Chu PY; Lin HY Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154 [TBL] [Abstract][Full Text] [Related]
34. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism. Zhang JJ; Zhu Y; Xie KL; Peng YP; Tao JQ; Tang J; Li Z; Xu ZK; Dai CC; Qian ZY; Jiang KR; Wu JL; Gao WT; Du Q; Miao Y Mol Cancer; 2014 May; 13():130. PubMed ID: 24884523 [TBL] [Abstract][Full Text] [Related]
35. TGF-beta1 down-regulates ICAM-1 expression and enhances liver metastasis of pancreatic cancer. Sawada T; Kimura K; Nishihara T; Onoda N; Teraoka H; Yamashita Y; Yamada N; Yashiro M; Ohira M; Hirakawa K Adv Med Sci; 2006; 51():60-5. PubMed ID: 17357279 [TBL] [Abstract][Full Text] [Related]
36. Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Erkan M; Weis N; Pan Z; Schwager C; Samkharadze T; Jiang X; Wirkner U; Giese NA; Ansorge W; Debus J; Huber PE; Friess H; Abdollahi A; Kleeff J Mol Cancer; 2010 Apr; 9():88. PubMed ID: 20416094 [TBL] [Abstract][Full Text] [Related]
37. miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients. Zou Y; Li J; Chen Z; Li X; Zheng S; Yi D; Zhong A; Chen J Carcinogenesis; 2015 Jun; 36(6):676-84. PubMed ID: 25863127 [TBL] [Abstract][Full Text] [Related]
38. Identifying a baicalein-related prognostic signature contributes to prognosis prediction and tumor microenvironment of pancreatic cancer. Zhang C; Lei D; Zhou Y; Zhong T; Li X; Ai W; Zheng B; Liu J; Piao Y; Yan Z; Lai Z Front Immunol; 2023; 14():1223650. PubMed ID: 37575248 [TBL] [Abstract][Full Text] [Related]
39. Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma. Dong Y; Tian J; Yan B; Lv K; Li J; Fu D Pathol Oncol Res; 2021; 27():1609822. PubMed ID: 34290570 [TBL] [Abstract][Full Text] [Related]
40. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. Yoshida J; Ishikawa T; Endo Y; Matsumura S; Ota T; Mizushima K; Hirai Y; Oka K; Okayama T; Sakamoto N; Inoue K; Kamada K; Uchiyama K; Takagi T; Naito Y; Itoh Y Oncol Rep; 2020 Jul; 44(1):371-381. PubMed ID: 32627027 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]